SOMERSET, N.J., March 9, 2017 – More than one percent of young men who took finasteride for 206 days or longer developed persistent erectile dysfunction (PED) that lasted an average of 4.2 years after drug discontinuation, according to a new study published today in PeerJ. In all, researchers examined the electronic medical records (EMR) of […]
Tag Archives: suicidal ideation
Предположение о том, что сексуальные побочные эффекты появляются в начале терапии финастеридом, а затем возвращаются к нормальному состоянию, «неточно», — говорят исследователи из Медицинской школы Бостонского университета.
SOMERSET, N.J., Aug. 26, 2015 – Twenty-five percent of men currently taking finasteride or dutasteride (brand names Proscar and Avodart) for the treatment of benign prostate enlargement (BPH), appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss are also at risk for adverse events elicited by […]
Клиническое исследование постфинастеридного синдрома запущено в Миланском университете и Миланском университете
SOMERSET, N.J., Dec. 9, 2014 – The Post-Finasteride Syndrome Foundation today announced the funding of a third clinical study on post-finasteride syndrome (PFS), this one a collaboration between the University of Milano-Bicocca and the University of Milano, both in Italy. Titled “Rare, but Serious and Persistent, Side Effects of 5α Reductase Inhibitors (5ARI): Why Do […]
Количество стран, подключившихся к PFSFoundation.org, выросло на 29% в 2013 году
SOMERSET, N.J., Jan. 6, 2014 – The number of nations that logged onto the Post-Finasteride Syndrome Foundation website rose 29 percent in 2013, according to Google Analytics. In all, users in 120 countries outside the United States—or 61 percent of the world (as defined by the 195 nations recognized by the U.S. Department of State)—accessed […]
Напоминание: сообщить о симптомах PFS в FDA MedWatch
SOMERSET, N.J., Oct. 29, 2013 – The Post-Finasteride Syndrome Foundation is reminding PFS patients to report all persistent side effects to the FDA MedWatch program. MedWatch is the U.S. Food and Drug Administration’s system for detecting safety-hazard signals for pharmaceutical products and medical devices. If a signal is detected, the FDA can issue safety alerts, […]
Ежегодное обращение Фонда PFS за 2013 год
Aug. 4, 2013 Dear Friends: When we incorporated the Post-Finasteride Syndrome Foundation in July 2012, our mission was clear: To fund research on the characterization, underlying biologic mechanisms and treatments of PFS while raising public awareness of this often life-altering condition afflicting thousands of men the world over. Now, on the occasion of our one-year […]
Спонсоры Фонда «Финастеридный синдром» Круглый стол PFS для медицинских исследователей на Международном совещании по стероидам и нервной системе
SOMERSET, N.J., Nov. 5, 2012 – The Post-Finasteride Syndrome Foundation is sponsoring a round-table discussion on PFS at the University of Milan’s 7th International Meeting on Steroids and the Nervous System conference in Torino, Italy, Feb. 19, 2013. Titled «Effects of Finasteride Treatment on the Nervous System,» the event is being organized by Roberto Melcangi, […]
Фонд запускает веб-сайт для финансирования исследований пост-финастеридного синдрома
The Post-Finasteride Syndrome Foundation today launched its website, PFSFoundation.org. The Post-Finasteride Syndrome Foundation is dedicated to helping fund research on the characterization, underlying biologic mechanisms and treatments of the post-finasteride syndrome (PFS).